alkaptonuria

Alkaptonuria results from a deficiency of homogentisate 1,2-dioxygenase, an enzyme in the tyrosine/phenylalanine degradation pathway that converts homogentisic acid to maleylacetoacetic acid. This enzymatic block causes accumulation of homogentisic acid in blood and tissues, which is excreted in urine and oxidizes to a dark pigment upon exposure to air, giving urine a characteristic dark/black color when left standing. The condition is inherited in an autosomal recessive pattern, with the gene (HGD) located on chromosome 3.

Clinically, patients may be asymptomatic in childhood, with darkening urine as the primary early sign (often noticed by parents when diapers turn black). Over time, homogentisic acid deposits in connective tissue (collagen), causing ochronosis—a bluish-black pigmentation visible in cartilage (ears, nose), sclera, and skin. This pigment deposition leads to progressive degenerative arthropathy, particularly affecting the spine (ochronotic spondylosis) and large joints, due to weakening of cartilage integrity. Patients may also develop cardiac valve calcification/stenosis (especially aortic valve) and renal or prostate stones due to homogentisic acid deposition.

Diagnosis is confirmed by elevated homogentisic acid levels in urine (via gas chromatography-mass spectrometry) and can be supported by genetic testing. There is no definitive cure; management is largely symptomatic, including pain control, physical therapy, and joint replacement for severe arthropathy. Nitisinone, an inhibitor of an upstream enzyme (4-hydroxyphenylpyruvate dioxygenase), has been used to reduce homogentisic acid production, though its long-term benefit on joint outcomes is still under study. Dietary restriction of phenylalanine and tyrosine may also help reduce substrate accumulation.

This condition is a classic example tested on USMLE for inborn errors of amino acid metabolism, specifically in the tyrosine degradation pathway, and is often contrasted with other related conditions like tyrosinemia and phenylketonuria (which involve different enzymes in the same pathway).